Purine biosynthesis enzymes and replicating DNA

This target profile represents a composite of molecular entities and biological processes essential for the proliferation of T lymphocytes, specifically focusing on the enzymes of the purine biosynthetic pathway and the integrity of replicating DNA. T cells are uniquely dependent on the de novo purine synthesis pathway, rather than the salvage pathway, for their expansion during an immune response. Key enzymes in this process, such as Inosine-5'-monophosphate dehydrogenase (IMPDH), are targeted by immunosuppressive agents to deplete the pool of available guanosine nucleotides. Additionally, antimetabolite drugs like thiopurines act as fraudulent bases that are incorporated into the DNA of replicating T cells, causing structural damage, mismatch repair activation, and subsequent cell death. By disrupting these metabolic and replicative requirements, therapeutic intervention effectively suppresses unwanted immune activity in the context of organ transplantation and autoimmune disorders.

Other names

Purine metabolism enzymesDe novo purine synthesis pathwayThiopurine targetsIMPDH and DNA incorporation

Inhibition of de novo purine synthesis via enzymes like IMPDH and phosphoribosyl pyrophosphate amidotransferase, alongside the incorporation of fraudulent thiopurine nucleotides into replicating DNA, leading to chain termination and apoptosis in T lymphocytes.